Persones / Equip Humà

Rosa Bou Torrent

Buscador de publicacions

Publicacions

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Borlan S, Gimenez-Roca C and Rivera J.

    Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population

    RHEUMATOLOGY INTERNATIONAL . 36(7): 905-910. Nº de cites: 29

    [doi:10.1007/s00296-016-3499-y]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E and Calzada-Hernández J.

    Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 34(3): 139-144. Nº de cites: 15

  • Calzada-Hernández J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Ricart S, Martín-de-Carpi J, García de Vicuña-Muñoz C, Torrente V, Sánchez-Manubens J, Giménez-Roca CI, Rozas L, Juncosa-Morros T, Fortuny-Guasch C and Noguera-Julián A.

    Tuberculosis in pediatric patients treated with anti-TNFa drugs: a cohort study

    PEDIATRIC RHEUMATOLOGY . 13: 54-54. Nº de cites: 34

    [doi:10.1186/s12969-015-0054-4]

  • Anton-Lopez J, Calvo I, Fernández-Martin J, Gamir ML, Merino R, Jimenez-Treviño S, Sevilla B, Cabades F, Bou-Torrent R and Arostegui JI.

    Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 33(6): 67-71. Nº de cites: 19

  • Bou-Torrent R, Adán A, Borrás F, Bravo B, Calvo I, De Inocencio J, Díaz J, Escudero J, Fonollosa A, García de Vicuña-Muñoz C, Hernández V, Merino R, Peralta J, Rúa MJ, Tejada P and Anton-Lopez J.

    Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus

    RHEUMATOLOGY INTERNATIONAL . 35(5): 777-785. Nº de cites: 72

    [doi:10.1007/s00296-015-3231-3]

  • Giménez-Roca CI, Iglesias-Jimenez E, Torrente-Segarra V, Bou-Torrent R, Sánchez-Manubens J, Calzada-Hernández J, Samuel Hernandez Baldizon, Ricart S and Anton-Lopez J.

    Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age

    RHEUMATOLOGY INTERNATIONAL . 35(2): 323-326. Nº de cites: 12

    [doi:10.1007/s00296-014-3103-2]

  • Bou-Torrent R, Iglesias-Jimenez E and Anton-Lopez J.

    Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis

    CURRENT RHEUMATOLOGY REPORTS . 16(8): 437-437. Nº de cites: 12

    [doi:10.1007/s11926-014-0437-4]

  • Iglesias-Jimenez E, Torrente V, Bou-Torrent R, Ricart S, Maria Isabel Gonzalez Fernandez, Sánchez-Manubens J, Calzada-Hernández J and Anton-Lopez J.

    Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-alpha therapy: a clinical practice observational study of patients who discontinued treatment

    RHEUMATOLOGY INTERNATIONAL . 34(8): 1053-1057. Nº de cites: 22

    [doi:10.1007/s00296-013-2884-z]

  • Sánchez-Manubens J, Bou-Torrent R and Anton-Lopez J.

    Diagnosis and classification of Kawasaki disease

    JOURNAL OF AUTOIMMUNITY . 48-49: 113-117. Nº de cites: 48

    [doi:10.1016/j.jaut.2014.01.010]

  • Torrente V, Bou-Torrent R, Ricart S, Santin-Riba P, Rodríguez N, Ros J and Anton-Lopez J.

    Leflunomide Use in Juvenile Idiopathic Arthritis Following Methotrexate Discontinuation: A One-Year Clinical Practice Retrospective Review

    Annals of Paediatric Rheumatology . 3(1): 26-28.